Samsung Biologics reports fourth quarter and fiscal year 2024 financial results Recorded Q4’24 consolidated revenue of KRW 1.26 trillion Recorded FY’24 consolidated revenue… CISION PRNewswireJanuary 22, 2025
2025 Japan Prize Laureates Announced TOKYO, Jan. 22, 2025 /PRNewswire/ — The Japan Prize Foundation announced the… CISION PRNewswireJanuary 22, 2025
Press ReleaseCP AXTRA Partners with Tencent Cloud: Catalysing a Digital Transformation in Retail Newly signed agreement encompasses IaaS and artificial intelligence solutions to enhance customer… CISION PRNewswireJanuary 22, 2025
Akeso Received Payment for the Development Collaboration on Tagitanlimab HONG KONG, Jan. 22, 2025 /PRNewswire/ — On January 22, 2025, Akeso Inc.… CISION PRNewswireJanuary 22, 2025
To answer three key questions about economic globalization BEIJING, Jan. 22, 2025 /PRNewswire/ — A report from People’s Daily: In… CISION PRNewswireJanuary 22, 2025
Press ReleaseThe 7th "HK Digital Advertising Start-ups X Publishing (Writers) Promotion Support Scheme" Unveiling 12 Selected Teams of Local Digital Advertising Start-ups & Emerging Writers… CISION PRNewswireJanuary 22, 2025
Press ReleasePCX Markets Earns B Corp Certification SINGAPORE, Jan. 22, 2025 /PRNewswire/ — PCX Markets, a marketplace for audited, traceable… CISION PRNewswireJanuary 22, 2025
Hyundai ADM Unveils a "New Paradigm in Cancer Treatment" – Preclinical Study Shows Promise for Continuous Oral Chemotherapy with Lowered Side Effects Risks SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ — Hyundai ADM Bio (Co-CEOs Taek-Sung… CISION PRNewswireJanuary 22, 2025
